Prevalence of unruptured intracranial aneurysms, with emphasis on sex, age, comorbidity, country, and time period: a systematic review and meta-analysis.
Monique Hm Vlak, Ale Algra, Raya Brandenburg...
https://pubmed.ncbi.nlm.nih.gov/21641282/Actively Recruiting
Led by Ming Lv · Updated on 2025-12-02
188
Participants Needed
1
Research Sites
28 weeks
Total Duration
Researchers are investigating the safety and effectiveness of two anesthesia methods, general anesthesia GA and local anesthesia LA, in patients with unruptured intracranial aneurysm UIA undergoing flow diverter FD placement. UIA is a condition affecting 2%-7% of the population, and rupture can lead to high rates of disability and death. Although FD placement under GA is common, some studies suggest LA might be feasible with fewer complications, but these studies have limitations. This trial aims to provide more reliable evidence by comparing GA and LA in a randomized controlled design. Participants will be randomly assigned to one of two groups. The LA group will receive local anesthesia only at the femoral artery puncture site without sedation drugs. The GA group will receive local anesthesia plus fast-induction general anesthesia involving tracheal intubation or laryngeal mask insertion with medications like isoproterenol, remifentanil, and muscle relaxants. The study will closely monitor the procedure and anesthesia effects during and after the intervention. During the study, participants will be followed for 90 days after the FD placement. Researchers will assess neurological status, cognitive function, newly developed cerebral ischemic areas, complication rates, mortality, pain levels, anesthesia and operative times, vasospasm incidence, hospitalization length, and costs. Safety and effectiveness outcomes will be carefully recorded to understand the impact of anesthesia choice on patient recovery and procedure success.
CONDITIONS
General Anesthesia vs Local Anesthesia for Endovascular Treatment in Patients With Unruptured Intracranial Aneurysm Using Flow Diverter
L
Linggen Dong, MD
M
Ming Lv, Ph D.
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Ming Lv
Lead Sponsor
Beijing Chao Yang Hospital
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Until discharge, approximately 1 week
Participants receive either local anesthesia or general anesthesia during endovascular treatment for unruptured intracranial aneurysm using a flow diverter.
1 procedure visit and hospital stay
Duration - 90 days after intervention
Participants are monitored for neurologic status, cognitive function, complications, and recovery after the intervention.
Visits at 12 hours, 24 hours, 7 days, and 90 days post-intervention
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Monique Hm Vlak, Ale Algra, Raya Brandenburg...
https://pubmed.ncbi.nlm.nih.gov/21641282/Claus Z Simonsen, Leif H Sørensen, Niels Juul...
https://pubmed.ncbi.nlm.nih.gov/27405859/Saujanya Rajbhandari, Hidetoshi Matsukawa, Kazutaka Uchida...
https://pubmed.ncbi.nlm.nih.gov/36009139/Nohra Chalouhi, Rohan Chitale, Robert M Starke...
https://pubmed.ncbi.nlm.nih.gov/23345630/Tibor Becske, Waleed Brinjikji, Matthew B Potts...
https://pubmed.ncbi.nlm.nih.gov/28362885/Huibin Kang, Yu Zhou, Bin Luo...
https://pubmed.ncbi.nlm.nih.gov/33447904/H Ujiie, K Sato, H Onda...
https://pubmed.ncbi.nlm.nih.gov/8248967/Bin Luo, Huibin Kang, Hongqi Zhang...
https://pubmed.ncbi.nlm.nih.gov/33224273/Laurent Pierot, Laurent Spelle, Jérôme Berge...
https://pubmed.ncbi.nlm.nih.gov/30297539/Adnan H Siddiqui, Peter Kan, Adib A Abla...
https://pubmed.ncbi.nlm.nih.gov/22710418/Ming Lv
Lead Sponsor
Beijing Chao Yang Hospital
Collaborating Sponsor